Rikvin Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.05 Cr
- Satisfied Charges ₹ 5.00 M
- Revenue Growth 27.80%
- Profit Growth 59.58%
- Ebitda 31.74%
- Net Worth 79.62%
- Total Assets -0.10%
About Rikvin Biotech
Rikvin Biotech Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2017 (Seven years and eight months 19 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.05 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Laxmi Badarla and Trinadha Badarla serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U15549TG2017PTC117013
- Company No.
117013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Rikvin Biotech Private Limited offer?
Rikvin Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Feed Additives, Animal Feed Supplement, Poultry Feed, Medical Laboratory Instruments, VTM Kit Raw Materials.
Who are the key members and board of directors at Rikvin Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmi Badarla  | Director | 11-May-2017 | Current |
| Trinadha Badarla | Director | 28-May-2020 | Current |
Financial Performance of Rikvin Biotech.
Rikvin Biotech Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 27.8% increase. The company also saw a substantial improvement in profitability, with a 59.58% increase in profit. The company's net worth Soared by an impressive increase of 79.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rikvin Biotech?
In 2021, Rikvin Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rikvin Greentech India Private LimitedLaxmi Badarla and Trinadha Badarla are mutual person
- Chaitra Universal Formulations Private Limited
Laxmi Badarla and Trinadha Badarla are mutual person
- Rainbow Healthcare Products Private Limited
Laxmi Badarla and Trinadha Badarla are mutual person
Charges (Loans)
₹10.50 M
₹5.00 M
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 2024 | State Bank Of India | ₹1.05 Cr | Open |
| 17 Nov 2021 | Axis Bank Limited | ₹5.00 M | Satisfied |
How Many Employees Work at Rikvin Biotech?
Unlock and access historical data on people associated with Rikvin Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rikvin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rikvin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
